WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 350 participants.
Also called NCT03173534
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 350 participants
- Registry
-
NCT03173534
-
- Other papers using this trial's data
- Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03173534. Randomized; no masking; primary purpose prevention. Start 2017-12-15 (actual); primary completion 2022-12-06 (actual). Results posted on 2024-05-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
- Condition
- Atrial Fibrillation
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- WATCHMAN
- Intervention (Device)
- TAVR (transcatheter aortic valve replacement)
- Lead sponsor
- samir kapadia
- Collaborator
- Boston Scientific Corporation
- Collaborator
- The Cleveland Clinic
Record details
- Record id
cardio:ct-nct03173534- Content hash
8a96dfcc0f1c74d98fc7709c5881fb5ef5919ac66ee41dbbbb03710508222c02